Top Notch cancer stem cells by paracrine NF-κB signaling in breast cancer

被引:0
作者
Weizhou Zhang
Sergei I Grivennikov
机构
[1] University of Iowa/Carver College of Medicine,Department of Pathology
[2] Cancer Prevention and Control Program,Fox Chase Cancer Center
来源
Breast Cancer Research | / 15卷
关键词
Breast Cancer; Cancer Stem Cell; Notch Signaling; Denosumab; Notch Pathway;
D O I
暂无
中图分类号
学科分类号
摘要
Cancer stem cells are likely to play critical roles in metastasis, therapy resistance, and recurrence of hematological and solid malignancies. It is well known that the stem cell niche plays a key role for asymmetric division and homeostasis of normal stem cells, whereas cancer stem cells seem to use these niches. Among many pathways involved in self-renewal of cancer stem cells, nuclear factor-kappa B (NF-κB) signaling has been documented to promote their expansion in a cell-autonomous fashion. A recent study, however, suggests that paracrine NF-κB activation promotes the expansion of cancer stem cells through the activation of Notch in basal-type breast cancer cells.
引用
收藏
相关论文
共 148 条
[1]  
Shostak K(2011)NF-kappaB, stem cells and breast cancer: the links get stronger Breast Cancer Res 13 214-899
[2]  
Chariot A(2010)Immunity, inflammation, and cancer Cell 140 883-1313
[3]  
Grivennikov SI(2013)NF-kappaB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype Nat Commun 4 2299-2735
[4]  
Greten FR(2009)Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature Cancer Res 69 1302-1847
[5]  
Karin M(2011)The JAK2/STAT3 signaling pathway is required for growth of CD44(+)CD24(−) stem cell-like breast cancer cells in human tumors J Clin Invest 121 2723-2021
[6]  
Yamamoto M(2013)Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling Breast Cancer Res 15 R21-1646
[7]  
Taguchi Y(2009)HER-2, notch, and breast cancer stem cells: targeting an axis of evil Clin Cancer Res 15 1845-4002
[8]  
Ito-Kureha T(2009)Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab Clin Cancer Res 15 2010-2811
[9]  
Semba K(2013)HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab Cancer Res 73 1635-931
[10]  
Yamaguchi N(2007)IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland J Clin Invest 117 3988-4610